Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1/2 1

Status

Completed 18Recruiting 8Unknown 7Terminated 5Not yet recruiting 3Active not recruiting 3Withdrawn 1

Sponsor Class

OTHER 3

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Breast Neoplasms 424Neoplasms 281Carcinoma, Non-Small-Cell Lung 272Colorectal Neoplasms 236Prostatic Neoplasms 173Lung Neoplasms 172Carcinoma, Hepatocellular 157Stomach Neoplasms 126Leukemia, Myeloid, Acute 120Pancreatic Neoplasms 118Multiple Myeloma 106Recurrence 99Uterine Cervical Neoplasms 97Squamous Cell Carcinoma of Head and Neck 89Neoplasm Metastasis 88Rectal Neoplasms 87Ovarian Neoplasms 81Triple Negative Breast Neoplasms 77Small Cell Lung Carcinoma 72Head and Neck Neoplasms 69Brain Neoplasms 68Esophageal Neoplasms 65Glioblastoma 64Endometrial Neoplasms 60Colonic Neoplasms 59Melanoma 55Hematologic Neoplasms 53Precursor Cell Lymphoblastic Leukemia-Lymphoma 48Motor Activity 48Carcinoma, Renal Cell 47

Interventions

selinexor 1ponatinib 1neratinib 1cobimetinib 1ceritinib 1brigatinib 1abemaciclib 1Radiosurgery 1Immunotherapy, Adoptive 1Etoposide 1Doxorubicin 1Colchicine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Not yet recruiting × Interventional × Carcinoma, Pancreatic Ductal × Clear all
NCT07153289 2025-09-03

ResCPa

University Hospital Tuebingen

Phase 1/2 Not yet recruiting
38 enrolled
Gastrointestinal

Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal

NCT06813079 2025-02-18

Using Tumor Models to Determine Treatments

University Health Network, Toronto

Phase 2 Not yet recruiting
25 enrolled
Gastrointestinal

Carcinoma, Carcinoma, Pancreatic Ductal

NCT06573398 2024-08-27

Radiotherapy With Sequential Chemotherapy Combined With PD-1 Inhibitor and Thymalfasin for BRPC

Ruijin Hospital

Phase 2 Not yet recruiting
20 enrolled
Gastrointestinal

Carcinoma, Pancreatic Ductal

Data powered by HemOnc (CC BY 4.0) Colophon âš¡